Role of folate status and methylenetetrahydrofolate reductase genotype on the toxicity and outcome of induction chemotherapy in children with acute lymphoblastic leukemia

References

• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166–178.
   PubMed Web of Science ®Google Scholar
• Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2003;362:706–708.
   PubMed Web of Science ®Google Scholar
• Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471–2475.
   PubMed Web of Science ®Google Scholar
• Asim M, Zaidi A, Ghafoor T, et al. Death analysis of childhood acute lymphoblastic leukaemia; experience at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan. J Pak Med Assoc 2011;61:666–670.
   PubMed Web of Science ®Google Scholar
• Hafiz MG, Mannan MA. Nutritional status at initial presentation in childhood acute lymphoblastic leukemia and its effect on induction of remission. Mymensingh Med J 2008;17(2 Suppl.):S46–S51.
   PubMedGoogle Scholar
• Bauer J, Jürgens H, Frühwald MC. Important aspects of nutrition in children with cancer. Adv Nutr 2011;2:67–77.
   PubMed Web of Science ®Google Scholar
• Sadananda Adiga MN, Chandy S, Ramaswamy G, et al. Homocysteine, vitamin B12 and folate status in pediatric acute lymphoblastic leukemia. Indian J Pediatr 2008;75:235–238.
   PubMed Web of Science ®Google Scholar
• Robien K. Folate during antifolate chemotherapy: what we know . . . and do not know. Nutr Clin Pract 2005;20:411–422.
   PubMedGoogle Scholar
• Branda RF, Nigels E, Lafayette AR, et al. Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats. Blood 1998;92:2471–2476.
   PubMed Web of Science ®Google Scholar
• Alati T, Worzalla JF, Shih C, et al. Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid. Cancer Res 1996;56:2331–2335.
   PubMed Web of Science ®Google Scholar
• Kawakita D, Matsuo K, Sato F, et al. Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma. Ann Oncol 2012;23:186–192.
   PubMed Web of Science ®Google Scholar
• Shitara K, Muro K, Ito S, et al. Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer. Cancer Epidemiol Biomarkers Prev 2010;19:1311–1319.
   PubMed Web of Science ®Google Scholar
• Scagliotti GV, Shin DM, Kindler HL, et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 2003;21: 1556–1561.
   PubMed Web of Science ®Google Scholar
• D’Angelo V, Ramaglia M, Iannotta A, et al. Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate. Leuk Lymphoma 2013;54:2639–2644.
   PubMed Web of Science ®Google Scholar
• Kantar M, Kosova B, Cetingul N, et al. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma 2009;50:912–917.
   PubMed Web of Science ®Google Scholar
• Yang L, Hu X, Xu L. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicity in acute lymphoblastic leukemia: a meta-analysis. Tumor Biol 2012;33:1445–1454.
   PubMed Web of Science ®Google Scholar
• de Benoist B. Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull 2008; 29(2 Suppl.):S238–S244.
   PubMed Web of Science ®Google Scholar
• United States, Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI). Common Terminology Criteria for Adverse Events (CTCAE). Ver. 4.03. Bethesda, MD: NCI; 2010.
   Google Scholar
• Kumar N, Shekhar C, Kumar P, et al. Kuppuswamy's socioeconomic status scale-updating for 2007. Indian J Pediatr 2007; 74:1131–1132.
   PubMed Web of Science ®Google Scholar
• Borsi JD, Wesenberg F, Stokland T, et al. How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia. Eur J Cancer 1991;27:1006–1009.
   Google Scholar
• Graham ML, Shuster JJ, Kamen BA, et al. Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study. Cancer Chemother Pharmacol 1992;31:217–222.
   PubMed Web of Science ®Google Scholar
• Taneja S, Bhandari N, Strand TA, et al. Cobalamin and folate status in infants and young children in a low-to-middle income community in India. Am J Clin Nutr 2007;86:1302–1309.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy K, Madhavan Nair K. Importance of folate in human nutrition. Br J Nutr 2001;85(Suppl. 2):S115–S124.
   PubMed Web of Science ®Google Scholar
• Moody K, Charlson ME, Finlay J. The neutropenic diet: what's the evidence? J Pediatr Hematol Oncol 2002;24:717–721.
   PubMed Web of Science ®Google Scholar
• Lindenbaum J, Allen RH. Clinical spectrum and diagnosis of folate deficiency. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker; 1995.
   Google Scholar
• Bostrom BC, Erdmann GR, Kamen BA. Systemic methotrexate exposure is greater after intrathecal than after oral administration. J Pediatr Hematol Oncol 2003;25:114–117.
   PubMed Web of Science ®Google Scholar
• Stover PJ. One-carbon metabolism-genome interactions in folate-associated pathologies. J Nutr 2009;139:2402–2405.
   PubMed Web of Science ®Google Scholar
• Jacques PF, Choumenkovitch SF. Mild MTHFR deficiency and folate status. In: MTHFR polymorphisms and disease. Georgetown, TX: Landes Bioscience; 2005. pp 54–70.
   Google Scholar
• Lucock MD. Synergy of genes and nutrients: the case of homocysteine. Curr Opin Clin Nutr Metab Care 2006;9:748–756.
   PubMed Web of Science ®Google Scholar
• Liu SG, Li ZG, Cui L, et al. Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population. Leuk Lymphoma 2011;52:1030–1040.
   PubMed Web of Science ®Google Scholar
• D’Angelo V, Ramaglia M, Iannotta A et al. Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate. Leuk Lymphoma 2013;54:2639–2644.
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, et al. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia. Pharmacogenomics J 2013;13:498–506.
   PubMed Web of Science ®Google Scholar
• Lennard L, Lilleyman JS, Maddocks JL. The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukemia. Br J Cancer 1986;53:115–119.
   PubMed Web of Science ®Google Scholar
• Schrøder H, Clausen N, Ostergård E, et al. Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1986;3:241–247.
   PubMed Web of Science ®Google Scholar